scholarly article | Q13442814 |
P819 | ADS bibcode | 2016PLoSO..1146997X |
P356 | DOI | 10.1371/JOURNAL.PONE.0146997 |
P932 | PMC publication ID | 4713075 |
P698 | PubMed publication ID | 26765738 |
P5875 | ResearchGate publication ID | 290442967 |
P50 | author | Xue-Xi Yang | Q87077651 |
P2093 | author name string | Jun Zhang | |
Ming Li | |||
Qi Tian | |||
Fen-Xia Li | |||
Ying-Song Wu | |||
Hai-Yan Gan | |||
Rong-Liang Liang | |||
Xu-Ping Xu | |||
P2860 | cites work | DNA Sequencing versus Standard Prenatal Aneuploidy Screening | Q22250872 |
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study | Q30414408 | ||
Quantification of Fetal DNA by Use of Methylation-Based DNA Discrimination | Q30987480 | ||
Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles | Q33747312 | ||
Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. | Q33767643 | ||
Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues | Q33838434 | ||
DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples | Q34301776 | ||
High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. | Q34340492 | ||
The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform | Q34374066 | ||
High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing | Q34464967 | ||
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies | Q35106099 | ||
Feasibility of noninvasive prenatal testing for common fetal aneuploidies in an early gestational window | Q35304735 | ||
Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
Screening for fetal aneuploidies at 11 to 13 weeks | Q37826399 | ||
ACMG statement on noninvasive prenatal screening for fetal aneuploidy. | Q38096182 | ||
Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. | Q39967854 | ||
Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis | Q46945516 | ||
Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing | Q47427812 | ||
Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma | Q47960026 | ||
Validation of ambiguous MLPA results by targeted next-generation sequencing discloses a nonsense mutation in the DMD gene. | Q51136384 | ||
Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies. | Q54285680 | ||
[Comparison of EGFR mutation status in paired pre- and post-chemotherapy serum for advanced pulmonary adenocarcinoma]. | Q54611055 | ||
Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics | Q61847812 | ||
Fetal Fraction in Maternal Plasma Cell-Free DNA at 11–13 Weeks’ Gestation: Effect of Maternal and Fetal Factors | Q61847823 | ||
Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma | Q74403995 | ||
Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy | Q85495453 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | massive parallel sequencing | Q6784807 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0146997 | |
P577 | publication date | 2016-01-14 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection | |
P478 | volume | 11 |
Q92236228 | A new set of DIP-SNP markers for detection of unbalanced and degraded DNA mixtures |
Q64055782 | An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study |
Q64107192 | Comparison of Efficiencies of Non-invasive Prenatal Testing, Karyotyping, and Chromosomal Micro-Array for Diagnosing Fetal Chromosomal Anomalies in the Second and Third Trimesters |
Q90461263 | Development of a comprehensive noninvasive prenatal test |
Q59792872 | Enrichment of the fetal fraction in non-invasive prenatal screening reduces maternal background interference |
Q55116442 | Evaluation of a novel non-invasive preimplantation genetic screening approach. |
Q48276430 | Haplotype-based Noninvasive Prenatal Diagnosis of Hyperphenylalaninemia through Targeted Sequencing of Maternal Plasma. |
Q64272413 | Next-generation sequencing and its clinical application |
Search more.